Kevin Appareti is Senior Director, Global Medical Science Liaison in the Chief Medical Office at Royal Philips. He leads the Key Opinion Leader Program and Medical Education Program. He works across Philips’ businesses, markets, and research to build strong internal and external relationships with Key Opinion Leaders (KOLs) and influencers. Kevin partners with internal business, market, and research leaders and external KOLs to develop Strategic KOL Engagement Programs to deliver strategic guidance, leverage clinical and scientific knowledge, foster peer-to-peer relationships, and support clinical and marketing evidence development and medical education in support of Philips development of meaningful innovations.

Dr. Peter Baumeister is currently a Medical Affairs professional with a career history that includes clinical and emergency medicine, basic science research, active duty enlistment in the Air Force and a short stint in art school that continues to supply him with entertaining anecdotes. He currently lives in Southern California, where he enjoys challenging the laws of physics with his eternally patient wife and 3 kids, all of whom are well-versed in basic first aid and trauma care. Professionally, he is interested in the sweet spot at the intersection of people, process, and technology in Medical Affairs and works to bring teams together that experience success greater than the sum of its individuals.

Mike has over 15 years of industry Medical Information experience on the client side and vendor side, with a history of successfully setting the vison, strategy and leading the implementation of innovative contact center services. Over the past 10 years, Mike has focused on regionalizing and globalizing medical information, and as Vice President of Global Medical Information at ProPharma Group, Mike leads the Medical Information group globally. Mike is active in several professional organizations and is a frequent speaker at various industry conferences. Mike received a BS in Pharmacy from Temple University and earned his Doctor of Pharmacy from Shenandoah University.

Stephanie Byrdé is an Advisor in Clinical Pharmacology for Eli Lilly and Company. During her tenure with Lilly, she has held various roles in clinical development, project management, and scientific communications, spanning early phase through late phase submissions and launches.

Alicia is Director and Team Lead for North America Oncology Medical Information at Pfizer Inc. Alicia has participated in the DIA Core Curriculum both as faculty and Chairperson, and in 2010 served as Chairperson for the DIA Annual March Med Comm Meeting. She has led the Fellow program for the DIA Med Comm Meeting from 2012 thru 2021. Alicia received her BS in Pharmacy from St. John’s University, and her PharmD from Albany College of Pharmacy. She spent 4 years at The University of Pittsburgh School of Pharmacy as a Nephrology Fellow and then as Assistant Professor of Pharmacy and Therapeutics. Alicia also worked in Medical Communications at Wyeth Pharmaceuticals and as Medical Director at CoMed Communications.

Ivy has 20+ years of experience in the pharmaceutical industry. She is a Principal Medical Information Lead at Genentech with experience across diverse therapeutic areas including Oncology, Rheumatology, Respiratory, Ophthalmology, Endocrinology, Neurology, Cardiovascular Disease, and various clinical conditions with an immunologic basis in pathophysiology. Prior to joining Genentech, she was a Clinical Pharmacist in General Surgery, Surgical Subspecialties, and Solid Organ Transplant at the University of California San Francisco (UCSF) Medical Center, and an Assistant Clinical Professor with the UCSF School of Pharmacy. Ivy received her PharmD from University of Tennessee Health Science Center.

Michael Church has been with Syneos Health for 15 years and working in the area of scientific communications for 19 years. Having started his career as a medical editor, Michael was a founding member of Syneos's clinical group and oversees a medical writing partnership that began with 5 associates in 2005 and has grown to its current state of 110 medical writers, editors, technical writers, and regulatory publishers. He is currently a Senior Director and leads the Syneos Strategic Resourcing Medical Writing Department.

Ed Cunningham, PharmD is Senior Director, Neurology Medical Science Liaison (MSL) Team Lead at Sunovion Pharmaceuticals Inc. Ed is based in Milwaukee, WI, and is responsible for overseeing the US Neurology MSL team. Prior to joining Sunovion, Ed was the Director of Specialty Care MSLs at Eisai Inc., leading the company’s Neuroscience and Metabolic MSL teams. Ed obtained his PharmD degree from Philadelphia College of Pharmacy and completed a 1-year Drug Information Residency with Janssen Pharmaceutica. Ed has been in the pharmaceutical industry for 17 years, working as a team leader in a variety of Medical Affairs functions, including Medical Information, Medical Education, Investigator Initiated Studies, and MSLs.

Rania Gaspo earned her Pharmacy Degree and her PhD at University of Montreal, Faculty of Pharmacy. She served as a Post-Doctoral fellow at Montreal Heart Institute before moving into industry in 1998 as a Senior Scientist. Rania joined Pfizer in 2003 where she held positions in medical information, medical affairs and clinical development in various therapeutic areas. She also served as a guest speaker for 24 years at University of Montreal. In her current role Rania leads a team of Experienced Medical Information Managers within Neuroscience and Pain category leadership in US and Canada and Globally. Rania authored/co-authored about 25 peer-reviewed publications and 50 scientific communications.

Kathleen Guindon, Director, Medical Science Liaison team at Puma Biotechnology is responsible for supervision of a team of six United States Based MSL’s. Kathy also maintains a territory within the US with her MSL team. Kathleen is a qualified registered nurse and holds the a Master’s degree from State University of New York at Buffalo in Oncology Clinical Nurse Specialist, and a doctoral degree from the University of Phoenix in Management and Organizational Leadership. She holds current memberships in NAPW, DIA, ASCO, ASH, & AACR. Kathleen’s varied background includes oncology nursing, oncology medical affairs, oncology clinical R&D, organizational management, public speaking, and publication in peer reviewed medical journals.

Kevin is currently a Field Operations and Resources Manager but has held a variety of roles in both US Commercial and Medical areas at Genentech. His experience includes strategic roles in oncology NME launches and line extensions. His relevant education includes a Pharm.D. and an MBA in Healthcare Administration. Prior to joining Genentech, Kevin spent over 5 years in healthcare management consulting, including PwC and Kaiser Permanente.

Jennie G. Jacobson is President of Jacobson Medical Writing. She earned her BA from Swarthmore College, and PhD from Harvard University. Jennie was a post-doc at Upjohn Laboratories and the University of Michigan before realizing being a medical writer would allow her all the fun of interpreting data without having to generate it. She rounded out her education with two AMWA certificates, a certificate in Medical Writing from U Chicago, and CMPP certification. In her 24 years as a medical writer, Jennie has written publications in a wide array of therapeutic areas including oncology, neurology, health outcomes research, gene therapy, endocrinology, respiratory disease, autoimmune disease, ophthalmology, and gastrointestinal disease.

In Craig’s more than 30 years working at Lilly, he has successfully worked in various positions in multiple therapeutic areas including neuroscience, diabetes and osteoporosis. Craig is a founding member of the Medical Science Liaison (MSL) program at Lilly where he worked in the New York City Metropolitan area for over 13 years in this field role. Craig spent 6 years as the MSL Trainer for Lilly USA and in 2017 became part of the Office of Medical Professional Development where is he assumed the role of the Global MSL trainer. Craig has been very active in developing benchmarking survey data on MSL standards across the pharmaceutical industry. Craig received the DIA Excellence in Service award in 2021.

Darryl Z. L’Heureux is an active and engaged member of the medical writing community. Dr. L’Heureux received his PhD in Cancer Biology and Masters in Pharmacy, Quality Assurance and Regulatory Affairs from Temple University. He has worked within the NCI cooperative group structure and across small biotech to large pharmaceutical companies. Returning to his early research interest in immuno-oncology/tumor biology, he leads Integrated Oncology Lung Development at Bristol-Myers Squibb. Combining his interest in science and education, Dr. L’Heureux continues to present lectures/roundtables at professional and educational events. He teaches scientific writing in the Professional Master’s Scientific Writing Program at Temple University.

Dr Marsh joined GSK on January 16, 2020 as the Director Medical Engagement and Communications. Most recently, she served at HEMA Biologics as the Director of Medical Affairs, Medical Information and Scientific Communication for HEMA Biologics, LLC from 2017-2020. Combining over 25 years of both clinical pharmacy and industry medical affairs experience, including 8+ years in leadership roles with globalization projects, Dr Marsh enjoyed working early in her career in ambulatory care and adult medicine inpatient settings, serving as adjunct faculty with Colleges of Pharmacy (UGA, USC, and Auburn). She began her career in industry GSK 19 years ago and since that time, continued opportunities working in a variety of medical affairs roles w

Dr. Petses is the Medical Information Regional Lead for the Americas at Sanofi US. She is responsible for management and implementation of strategic and tactical medical information objectives across several business units. She has directed teams of medical information professionals who have provided support for products across broad therapeutic areas. She has managed the development of digital communication channels and a data mining tool to improve analytics and insights gathering. Prior to joining Sanofi she completed a Drug Information Residency at Schering-Plough. She earned her Bachelor and Doctor of Pharmacy degrees from St. John’s University in New York.

David Price, PhD has been employed with Eli Lilly and Company since 2011. David began as a Psychiatry Medical Science Liaison. David took the opportunity to diversify his MSL experience by transitioning to MSL roles supporting Urology as well as Musculoskeletal therapeutic areas. In 2014, David shifted to US Field Medical Operations and capability development across numerous therapeutic areas and MSL teams. Prior to his current role, David was a Global MSL Trainer in Lilly’s Office of Medical Professional Development. In 2018, David started his current position as a Field Medical Advisor providing operational leadership, strategic oversight and chief of staff responsibilities for Lilly’s US Bio-Medicines MSL program.

Holli has worked in the Center for 15 years with responsibilities focused on customer experience, operations, training, monitoring, and quality systems. She is motivated to drive positive customer experiences while managing the operations and regulatory needs for the business. Holli uses customer input to drive operational efficiencies and continuous improvement with business partners such as brands, medical, quality, safety functions. She is actively involved in the management, leadership and partnership with TLAC’s outsourced supplier relationship to deliver on The Lilly Answers Center experience. Holli graduated from Indiana University with Spanish/Political Science degrees and completed her Masters in Instructional Systems Technology.

Founder and president of Whitsell Innovations, Inc., a medical writing firm headquartered in Chapel Hill, NC, Ms. Whitsell has over 25 years of experience, specializing in global submission strategy, regulatory medical writing, emerging technologies, and data visualization. Prior to founding WI, Ms. Whitsell was the assistant director of preclinical & clinical development at Inspire Pharmaceuticals and a team lead at GlaxoWellcome. She has degrees in biophysics and physics from Miami University and interned at Los Alamos National Laboratory.

Jim Wilkinson, PhD is an executive leader in global and US Medical Affairs, with over 22 years in the biopharma industry. His experience includes leading Global/US Medical Information, Global Publications, Global/US Medical Communications, Global Field-Based Medical, and US Medical Science Liaison (MSL) teams. Jim has worked in multiple therapeutic areas while also launching multiple products throughout the course of his career. He has extensive working knowledge of the commercialization process, compliance, product launches, company/product acquisition and integration, legal and regulatory guidelines, operations, omnichannel communications, and promotional review. Jim received his B.S. from UW-Madison and his Ph.D. from UM-Minneapolis.

Ann Winter-Vann earned her PhD in Molecular Cancer Biology from Duke University, where she was a predoctoral fellow of the Howard Hughes Medical Institute. Following a postdoctoral position in the Pharmacology Department at UNC-Chapel Hill, Ann joined Whitsell Innovations, Inc., where she is now a senior writer and manager. She has extensive experience in clinical regulatory writing and also provides consultations and training in medical writing. Ann has co-taught a science writing course for first-year biomedical graduate students at UNC-Chapel Hill. Ann is a past president of the Carolinas chapter and the current President of the American Medical Writers Association (AMWA).

David Bowers has 20+ years of experience managing pharmaceutical contact center programs at PPD. As Senior Director of Operations, David supports global medical information for pharmaceutical, biotechnology and medical device clients. He has a background in pharmacy, with a Doctorate of Pharmacy from the University of North Carolina in the United States. During his time at PPD, David has worked with over 30 client contact center programs providing medical information, pharmacovigilance and product complaint processing, patient adherence programs, REMS support and other services. David’s recent experience includes implementing contact center operations in the US, Europe, Latin America and Asia.

In her 25+ years of industry experience, Lynn has served in both individual and leadership positions within Medical Affairs at both large and start-up companies. She is currently Sr. Director, Medical Science Liaisons at BridgeBio, where she is building and leading a field medical team in the rare cardiovascular therapeutic area. Lynn is a transformative leader with proven excellence in building & developing high performing teams. Along with her leadership positions, Lynn is very active in growing/expanding the MSL profession across the industry and is a frequent invited speaker. She has also authored/ co-authored several MSL surveys highlighting and assessing the MSL role.

Poonam is currently a Team Lead within the Global Scientific Content group at Merck based in Kenilworth, NJ. She has global responsibility across the entire General Medicines portfolio with a large team covering key products. Most recently, Poonam was at Celgene in the Strategic Medical Communications and Innovation group. Prior to this, Poonam worked at Sanofi in the Medical Information Department for 12 years, at JNJ in the Global Competitive Intelligence group for 3 years, and at Parke-Davis in the MI Department for 3 years. She has 25 years of experience in Pharma and has 2 publications regarding Social Media and Medical Information Trends. Poonam chaired the 2019 DIA MASC meeting is now involved with DIA Annual.

David is an Advisor Scientific Communications at Eli Lilly and Company with over 20 years of regulatory, publication, and promotional scientific communications experience in the pharmaceutical industry. His work has included document authoring, team management, operations consulting, clinical research, and medical affairs. David is Chair of the American Medical Writers Association Medical Writing Certification Commission.

Eileen M. Girten is Director of Medical Writing at Pfizer and is experienced in regulatory and publications writing, submissions, and mentoring. She is an Adjunct Assistant Professor at the University of the Sciences in Philadelphia and has taught Regulatory Documentation Processes for the Biomedical Writing program. Eileen earned a BA in Chemistry from Rosemont College, an MS in Psychology from Saint Joseph’s University, and an MS in Biomedical Writing from the University of the Sciences in Philadelphia.

Pete Guillot is the president and founder of Centerfirst. Pete started Centerfirst in 2004 with the mission of helping pharma leaders make better decisions with insights derived from their contact centers. Centerfirst has worked with 11 of the top 20 bio-pharma companies and is a long term supporter of this DIA. Pete has an MBA from The University of Texas, and lives in Indianapolis, Indiana.

Monica Kwarcinski is currently the Vice President of Medical Affairs at Purdue Pharma. In this role Monica oversees Medical Information, MSLs, Medical Communications and Strategy, Health Economic and Outcomes Research, Epidemiology, and FDA Postmarketing Requirement studies. Prior to joining Purdue Pharma, Monica held various positions of increasing responsibilities within Abbott Laboratories Medical Affairs Department. She received her PharmD from Creighton University in Omaha, Nebraska followed by a Drug Information Residency University of North Carolina, Chapel Hill and Glaxo. Monica has 25+ years of industry experience and frequently speaks on topics related to industry medical communications compliance and department processes.

Sudip S. Parikh, PhD, serves as Senior Vice President and Managing Director for DIA Americas. He previously served as Vice President and General Manager of Health & Consumer Solutions at Battelle, leading its Healthcare Improvement, Public Health Research, and Consumer, Industrial, and Medical Technology Development teams in R&D supported by government and commercial clients. Dr. Parikh is a board member of Research America, the Friends of Cancer Research, and the Food Innovation Center. He was a Presidential Management Fellow at the National Institutes of Health, and was awarded a National Science Foundation Graduate Research Fellowship while earning his PhD in Macromolecular Structure and Chemistry from The Scripps Research Institute

Lucy graduated as a physician assistant, earned an MBA, and worked for seven years in sales and sales training with Bristol-Myers Squibb prior to serving as the Director of the Division of Drug Marketing, Advertising, and Communications and the Office of Training and Communications at FDA. For the last 18 years she has consulted with numerous pharmaceutical companies on promotional regulations/strategy, drug development and regulatory strategy, health policy, and has enjoyed training many professionals on advertising/promotional regulations.

Lisa has 23 years experience in the pharmaceutical industry as both a biochemist and scientific writer. She is a technical advisor for clinical pharmacology scientific communications and regulatory submissions. Lisa has expertise working on multidisciplinary teams across multiple geographies and phases of drug development.

Dr. Anne Arvizu is founder and CEO of RxER Communications Corp (www.rxercommunications.com). With 22 years of executive leadership experience in the pharma/biotech industry, she has served in key roles such as Head of Global Med Info, Knowledge Mgmt. and Literature Surveillance for Baxter, Baxalta & Shire; Member Executive, PhactMI; International Regional Head & Director of Med Comm/Med Info for GSK, LATAM; DIA MASC Program Committee & Track Chair; Podcast Host for ACMA (#V3Podcast); Board Member of AMWA and serves as Chair, South Florida YMCA Board of Directors. She currently engages biotech C-Suite and VP Level executive clients as an expert consultant for Medical Affairs Capabilities build, renovation, and value-based business expansion.

Attended the University of Michigan for undergrad and went on to the University of Connecticut for medical school. After completing his residency in internal medicine at the University of Chicago Hospital in 2002, he left clinical medicine to pursue a career in medical education. He is the President and Co-Founder of MDea, a creative medical education company in NYC, and The Doctor’s Channel, known as the “educational YouTube for doctors.” Michael serves as a Managing Director of BESTMSLs, a contract MSL organization, where he brings medical and technology expertise to field organizations. He is also one of the founders of the physician recruiting firm DrCruiter.com.

CAS at ASU creates knowledge networks to solve complex systems problems in biomedicine. Prior to ASU, Dr. Barker served as the deputy director of the National Cancer Institute where she planned and implemented the: Nanotechnology Alliance for Cancer; The Cancer Genome Atlas (TCGA) with NHGRI; Clinical Proteomics Technologies Initiative for Cancer; Physical Sciences-Oncology Centers; and national programs in biospecimens and bioinformatics. Prior to NCI, Dr. Barker served as a research scientist and subsequently senior executive at Battelle Memorial Institute, and a CEO of a public biotechnology company. She has received many awards for her work and service. She completed her Ph.D. degree at The Ohio State University.

Stephanie Brillhart joined inVentiv Health Clinical in 2012. As a Manager of Medical Writing for inVentiv Health, Stephanie currently oversees a team of writers who provide support for autoimmune and clinical pharmacology projects. Prior to working for inVentiv Health, Stephanie was the Manager of Clinical Science and Safety for an academic research organization, CPC Research, in Denver, CO. Stephanie earned a BA in Molecular Biology from the University of Denver, and an MS in Clinical Investigation from the Massachusetts General Hospital Institute of Health Professions.

Michelle Carey is a Principal Medical Writer with inVentiv Health. She earned her BS in Biotechnology from the National University of Ireland Galway and a PhD in Pharmacology from University College Cork, Ireland.

Dale Cooke is president of PhillyCooke Consulting, which helps prescription product marketers use 21st century technology to provide healthcare information while ensuring compliance with FDA regulations written in the 1960s. Dale is the author of Effective Review & Approval of Digital Promotional Tactics, now in its second edition, which was published by the Food & Drug Law Institute.

Torrey Cope advises and represents clients in a full range of regulatory, enforcement, litigation, and transactional matters involving FDA issues. He has been recognized as a “Life Sciences Star” in the FDA: Pharmaceutical category by LMG Life Sciences since 2016 and has been included in The Best Lawyers in America for FDA Law since 2018. He was also named a “Rising Star” for Life Sciences in LMG's 2017 and 2018 Expert Guides.

Lisa is an assistant professor of Writing Studies at Hofstra University, where she teaches a wide range of courses including scientific writing, health communication, medical humanities, and narrative medicine. Her research interests include vaccination policy, medical humanities, publication ethics, regulatory writing, and theories of the body. Lisa is the lead author of Good Publication Practice Guidelines for Company-Sponsored Biomedical Research: 2022 Update and the editor of Regulatory Writing an Overview.

Dr. DeWyngaert trained as a molecular biologist and has been actively involved in both research and business development roles for over 30 years. He has provided operational, clinical, managerial, consulting, and litigation services to various segments of the health care industry. He specializes in assisting pharmaceutical manufacturers, biotechnology, and medical device companies with identifying and mitigating regulatory risks, valuing intellectual property and litigation support.

Dr. Dubroff has been at Genentech for 9 years. He currently leads the Managed Care Liaison team, who are the science interface with managed care customers. Prior to Genentech, he was the VP for Health Excellence Partners at Highmark Blue Cross/Blue Shield. Before Highmark, Michael was a National Medical Director at GSK and a Sr. Medical Director at Blue Cross of Philadelphia. After receiving a BA from LaSalle College, a Doctor of Osteopathy from the Philadelphia College of Osteopathic Medicine, a Pediatric Residency at Hahnemann Medical College and Hospital, and a Fellowship in Pediatric Rehabilitation from St. Christopher’s Hospital, he practiced general pediatrics and cared for handicapped children.

In her 18 years of medical writing experience, Deborah Frisby has played a key role in leading large teams through the process of planning, writing, and coordinating the completion of the many clinical documents needed for marketing authorization applications. Her experience also includes writing the clinical documents needed for the initiation and completion of clinical trials across all phases of drug development. She is currently employed by Eli Lilly and Company.

Avikk is co-founder and CEO of Kernel. Previously, he directed strategic mobile initiatives at Intuit where his team was responsible for product strategy, mergers & acquisitions and best-practice innovations in the wireless ecosystem. Before Intuit, Avikk was vice president, marketing and business development at Mercora and worked in corporate development at RealNetworks. Avikk serves on the board of trustees at the Ghose Foundation. He is on the board of advisors at Virtual Mobile Technologies (Pty) Ltd in Cape Town, South Africa and is a senior advisor at Endeavor. Avikk received an undergraduate degree in economics from the University of Washington and an MBA from New York University.

Dr. Giffin is responsible for ensuring scientific resources, quality, compliant and fair balanced information delivery, establishing best practices in Medical Communications and providing leadership globally. Dr.Suzana Giffin is the AVP, Global Medical Affairs at Merck. Prior to joining Merck, she was at Amgen as Head of Global Scientific Communications and was an MSL with BErlex Oncology. Dr. Giffin received her PharmD from USC.

Cathi has held numerous roles in Marketing, Marketing Communications and Scientific Communications for nearly 35 years in the diagnostic, device, and pharmaceutical industries. Cathi works at Eli Lilly and Company as a manager in scientific communications for Autoimmune. Previously, Cathi wrote, managed and edited documents for device medical and regulatory purposes, including briefing documents, regulatory responses, 510(k) submissions, and clinical evaluation reports. She also developed new and updated device methods to improve timelines and quality of device-related documents. Cathi has also written, managed and edited compound scientific documents, including protocols, briefing documents, submissions, and abstracts/manuscripts.

Evelyn R. Hermes-DeSantis, PharmD, BCPS, is the Director for Research and Publications for phactMI and Professor Emerita at the Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey. She is dedicated to advancing and elevating the practice of medical information. She received both a BS in Pharmacy and a PharmD from Rutgers and completed a Drug Information specialty residency at the Medical College of Virginia Hospital in Richmond, Virginia prior to working at the University of Utah Hospital Drug Information Service. For 25 years she was the Director of Drug Information Services at Robert Wood Johnson University Hospital and a Clinical Professor at the Ernest Mario School of Pharmacy at Rutgers.

Taleen is currently the US lead for HIV Medical Information at Gilead Sciences. After graduating from USC School of Pharmacy she pursued a career in retail pharmacy, which provided experience in a variety of settings including management. She later had the opportunity to switch paths and move into the pharmaceutical industry at Gilead, where she has supported the cardiovascular, cardiopulmonary, and HIV portfolios.

Dawn Kirspel is Vice President of The Center For Client Retention, a NJ-based research firm specializing in measuring customer satisfaction and loyalty. Before being promoted to Vice President, Dawn served as Account Manager for various pharmaceutical and healthcare clients and as well as Director of Operations. In addition to today's responsibilities related to management of marketing and operations, Dawn has been successful in developing and managing consultative relationships with Fortune 500 clients, assisting them in improving the customer experience. Dawn holds a Bachelor’s Degree in Economics from Rutgers University and a Bachelor’s Degree in Internet Marketing from Full Sail University.

Dr. Jane E. Miller (Ph.D., Demography, University of Pennsylvania) is a Professor at the Institute for Health, Health Care Policy and Aging Research, and the Edward J. Bloustein School of Planning and Public Policy at Rutgers University. A specialist in quantitative communication and statistical literacy, she has written two books: The Chicago Guide to Writing about Numbers and The Chicago Guide to Writing about Multivariate Analysis, both in their second editions, and a series of related articles in teaching and research journals. Her research interests include relationships between poverty, child health, health insurance, and access to health care.

Robert Paarlberg is Principal of Paarlberg & Associates LLC, a consultancy specializing in regulatory policy, regulatory intelligence and global clinical trial disclosure strategy and operations. Prior to founding Paarlberg & Associates LLC, Bob worked at Pharmacia (Upjohn) and UCB. Bob is former Chair of DIA’s Clinical Trial Disclosure Community. Bob has more than 40 years of pharmaceutical industry experience with the vast majority of his experience in US and international regulatory affairs. Bob has been active in the clinical trial disclosure and transparency space since 2005.

Jamie received her PhD in pharmaceutical chemistry from the U. of Kansas in 1994, followed by a post-doctoral fellowship at the U. of Washington. She studied drug disposition (absorption, metabolism, distribution, excretion [ADME]) with an emphasis on drug transport across biological barriers. She joined the ADME department at Eli Lilly & Co. in 1997. Still within Lilly, she left the laboratory environment in 2003 and began her medical writing career, supporting diabetes and growth hormone disorders. For a brief period (2 years), she worked for a vendor writing company and then returned to Lilly, where she now provides medical writing support for the Clinical Pharmacology Department, focusing on Phase 1 studies.

Dr. Taetle is currently a member of Arizona Oncology, a statewide, multidisciplinary oncology group. His practice includes hematologic and solid tumor cancers, and benign hematology disorders, and is active in clinical research. He was previously on the faculty of the University of Arizona and University of California-San Diego, where he was active in clinical and basic science research, and medical education.

Mark is an IT and Data Privacy specialist with over 20 years’ experience. Much of his experience was gained in-house at IBM where he was Global Privacy Counsel for many years. He regularly advises many global companies on developing data privacy compliance programs. He has particular expertise in dealing with international data transfers matters and the development of ‘Binding Corporate Rules’.

Dr. Robin Winter-Sperry is currently the Global MSL Lead at Ipsen Biosciences in Cambridge, MA. Prior to joining Ipsen she was the Head of Global Field Based Medical Excellence and Insights at Sanofi Genzyme. Additionally Robin has extensive consulting experience as President of Scientific Advantage. She has been instrumental in Medical Affairs strategy and operations including mergers, transitions and Medical Affairs organizational design. She has pioneered the recognition of MSLs as a specialty in the biopharmaceutical and device industry and is responsible for creating and developing many of the industry’s leading Medical Affairs and Medical Liaison teams.

Matt graduated in 2008 with his Pharm.D. from Rutgers University and subsequently completed a post-doctoral fellowship in Medical Affairs. From 2008 to 2015, he held various responsibilities and roles within the Medical Affairs umbrella at Daiichi Sankyo. In 2016, Matt made a transition to Regulatory Affairs at Celgene, where he was responsible for ensuring regulatory compliance of US promotional materials. Most recently, Matt completed his MBA and was also appointed to a secondment opportunity as the Chief of Staff for Celgene's Global Regulatory Affairs group.

Patricia J. Zettler is an associate professor at Georgia State University College of Law. Her research focuses on medicine and biotechnology regulation, with an emphasis on the U.S. Food and Drug Administration (FDA). Before her current position, she served as a fellow at Stanford’s Center for Law and the Biosciences and as an associate chief counsel in FDA’s Office of the Chief Counsel. In addition to her legal background, Zettler has worked in NIH’s Department of Bioethics and the University of California San Francisco’s Program in Medical Ethics. She received her BA and JD, both with distinction, from Stanford.

Dr. Biagi serves as Clinical Site Management Team Lead for UCB, Inc. She brings over 20 years of experience within the pharmaceutical industry. She has held many memberships and designations over the years including positions with the American Medical Writers Association and the Georgia Pharmacy Association. Dr. Biagi received her PharmD and Drug Information Residency from Mercer University.

Elizabeth supports the organization by helping improve the patient experience, using service design. Her work incorporates design principles into key capabilities; co-creation with patients, proto-typing, and systems thinking. She leads the Patient Relationship Management capability, which offers the organization the opportunity to have a deeper patient engagement and to ultimately build trust with patients. Elizabeth’s role in the Patient Hub, builds on 20+ years of experience in the Pharmaceutical Industry (BMS, Pfizer) and Community Pharmacy. She also has held roles as the Director of Independent Medical Education for the Oncology Franchise, Publications Operations Lead, and Medical Information Lead for the Contact Center, at BMS.

Dr. Citrome is Clinical Professor of Psychiatry & Behavioral Sciences at New York Medical College in Valhalla, NY, and has a private practice in Pomona, NY. He is a member of the Board of Directors of the American Society of Clinical Psychopharmacology. Dr. Citrome is the Editor-in-Chief of the International Journal of Clinical Practice, published by Wiley. He is the author or co-author of over 500 published research reports, reviews, and book chapters in the biomedical literature.

Mary Anne Cronk is an accomplished influence marketer continuously striving to push the envelope via new and adapted techniques for evolving marketing and business strategies. Widely known as a practical visionary in the ‘big data’ field for creatively unearthing insights and meeting new objectives, she inspires others to “tell the customer’s story.” She currently taps into her innate intuition and foresight to “link,” creatively connect, and profitably harness, contextual insights from evolving communication channels, including integrating social media influencers into the mix. She has applied this competitive energy and passion across different businesses at Philips Healthcare for over 10 years.

Dr. Crowley-Nowick, is a respected expert in the pharmaceutical industry, bringing nearly 15 years of experience in medical affairs and clinical research. In 2008, Dr. Crowley-Nowick founded Zipher Medical Affairs, Co., LLC., a leading provider of medical affairs strategic consulting & MSL services. She has successfully led late stage biotech & pharma companies through multiple product launches across several therapeutic areas, such as oncology, cardiovascular, and diabetes. Dr. Crowley-Nowick’s patient-centric view & drive for improved patient care & outcomes have propelled her to shape the organization based on not only scientific integrity but also continual collaboration with emerging medical stakeholders.

Prior to joining Merck, Stephen spent 12+ years in medical affairs leadership roles working for Novo Nordisk and Novartis Pharmaceuticals Corporation, leading national teams supporting a variety of therapeutic areas. Before coming into industry in 2001, Stephen worked for a medical services organization in Southern California, managing global risk and a self-funded health plan for an integrated healthcare delivery system. He started his career in hospital and outpatient clinical practice, followed by running his own company, supporting provider groups in management of their drug utilization and delivery under financial risk arrangements.

Joe has been at Bristol-Myers Squibb for 7 years and is responsible for driving strategic innovation focused on improving internal and external customer experience for the Medical organization. Joe’s depth and breadth of expertise includes strategy, creative, technology, and operations. He’s played an integral role developing enterprise-wide digital standards, process/system overhauls and ground-breaking digital projects that have transformed the way both Commercial and Medical teams operate.

Tom Faria, Pharm.D., M.Sc. is currently the Executive Director and Global Medical Information lead at Celgene. He has over 13 years of experience within the pharmaceutical industry across many aspects of Medical Communications, including Medical Information, Global Medical Congress Planning and the development of innovative communications content, tools and channels.

Chad provides strategic direction to project teams for the creation of compelling market access stories along with medical content development. He is experienced in global medical communications with project teams to create a spectrum of deliverables (abstracts, posters, manuscripts, sales aids, dossiers, slide decks, and customized reports). His background includes 10 years of agency medical communications, 10 years in the pharmaceutical industry, 4 years in the US managed care industry, and 5 years of clinical practice. His experience includes serving as an industry liaison on the AMCP expert review panel that developed the first AMCP dossier format.

In her role, she provides counsel regarding various issues including healthcare regulation, FDA advertising and promotion laws, Lanham Act. Jamie provides legal support to the company on general antitrust matters and is a core participant in several industry groups including PhRMA and the MIWG. Jamie also serves on the Lilly Diabetes executive team and the General Counsel’s staff. Prior to her current role, Jamie served as Assistant Secretary and Corporate Securities Counsel for Lilly, where she worked with the Eli Lilly executive committee and board of directors. Before coming to Lilly, Jamie was an associate at Sidley Austin LLP in Chicago, IL. She is a graduate of DePaul University College of Law, and Purdue University.

Bonny is a data-preneur and founder of Data & Donuts--a popular blog creating a narrative between health data and the variability of interpretation and presentation. Patients, business types, people of all ages are contributing to the data flotsam and jetsam sought after by multiple industries and stake-holders. Filtering the digital exhaust to yield value and actual insights--a true 360 analyses--is the true objective.

David Meats is a Director of Regulatory Services and Medical Affairs at Certara. He has been a medical writer and manager for 23 years working in oncology, immuno-oncology, endocrinology, musculoskeletal, cardiac, hepatic, renal, and infectious disease therapeutic areas on nearly every available clinical document type. He specializes in leading and writing FDA and EMA regulatory submissions and an expert in technology development in regulatory services. David is also a co-chair for the Medical Writing track of the DIA 2024 conference, and has been a member of DIA for 8 years.

Crystal is an Associate Director of Operations at PPD and has worked in Medical Information for over 13 years. Prior to joining PPD, she worked for over 11 years in the community pharmacy setting.

Sarika Sood is the Head of AbbVie Global Medical Communications which includes Global Medical Information and Global Medical Publications. She has over 15 years of academic and pharmaceutical industry experience. Sarika has experience across many Medical Affairs capabilities including MSL leadership, Global Medical Information, Therapeutic Area Medical Teams. She has led and built teams at a global and local capacity. Sarika has had the opportunity to work in many therapeutic areas across the industry and enjoys being a strategic builder.

Andrea M. TenBarge, PharmD is a Consultant in Medical Digital Strategy and Capabilities at Eli Lilly and Company. She has led multiple projects implementing new technologies for medical information disclosure and preferred customer channels across Medical Affairs. Andrea obtained her PharmD from the University of Illinois at Chicago. Upon graduation, Andrea completed a 2-year Regulatory Pharmaceutical Fellowship specializing in Drug Information with Purdue University, Lilly, and the FDA.

Kay Uttech is VP for Strategic Initiatives at Indegene working with companies to build and optimize medical affairs services. She has more than 20 years’ experience in the pharmaceutical and medical device industry. Kay has held roles in Medical Affairs as a MSL and leading MSL teams in North America. Additionally, she has also held other responsiiblities in Medical Communication and Information; development of global scientific knowledge management systems; grants for ISS and medical education; and promotional review. Her current work is focused on leveraging technology to drive efficiency that optimizes the medical and scientiifc expertise of Medical Affairs teams.

Chi Chang, PharmD is an Associate Director in Medical Communications at Genentech, a member of the Roche Group. She leads a group of PharmDs dedicated to providing Medical product information, medical review of promotional materials, and customer insights for Genetech’s Respiratory and Ophthalmology Therapy Areas. Prior to joining Genentech in 2005, she served as Manager in Medical Information at Gilead Sciences and Clinical Pharmacy Coordinator of Pediatric Service at the UCSF Children’s Hospital. She received her Doctor of Pharmacy degree and completed a Clinical Pharmacy Practice Residency at the School of Pharmacy at the University of California, San Francisco.

Maureen has over 20 years of experience in Medical Affairs, including leadership roles in Medical Information, Medical Communications, and Field Medical. Maureen has been with Takeda for 9 years. She is currently Vice President Medical and Scientific Communications at Takeda. Previously, Maureen was Head of Global Medical Communications at Shire. Maureen has served on various DIA program committees. Prior to Takeda, Maureen held various positions of increasing responsibility including, Director of Medical Information at GlaxoSmithKline and Head of Medical Services at Incyte. Maureen has 10 years of clinical practice and teaching experience at Thomas Jefferson University Hospital and the University of the Sciences in Philadelphia.

Helle manages Medical Affairs writing, with a staff of Regional Leads and is responsible for special projects. She joined Johnson & Johnson, former Janssen Research Foundation (JRF), in 1997 and was closely involved in developing JRF’s first electronic submission. She led the oncology writing group and assumed early development MW for global Research units. She worked in the CDISC Glossary Group and in the standards developing organizations of HL7/RCRIM/CDISC Working Group for the Protocol Representation Model. She represented PhRMA on the ICH E3 Q&A Implementation Working Group. She’s a member of the TransCelerate Transparency Leadership Team, is the CSR Redaction Sub Team Co-Lead, and has 40+ years in the pharmaceutical industry.

Arlene Kray has over 10 years of industry experience with increasing levels of responsibility. She received her PhD in Pharmacology from Vanderbilt University. She completed Post-doctoral Training at Carnegie Mellon University and then pursued a PharmD at Duquesne University while working as a clinical scientist and medical writer. She has been with PRA since 2016 and currently leads a team of medical writers and managers supporting Oncology. She also teaches Pharmacology to Nursing Students at the local community college.

Michael Pietrack is the Pharmaceutical Industry's leading third-party recruiter. Michael heads up TMAC Direct, an executive search firm is the direct-hire capability of The Medical Affairs Company. TMAC Direct fills critical hires in Medical Affairs and Clinical Development with a specialty in field Medical Affairs and Physician Recruitment. Michael has made a name for himself not only in the Pharmaceutical Industry but in the Recruiting Industry as well. In 2013, he was named the #1 Worldwide Recruiter, and in 2015, he became a member of The Pinnacle Society, which is a group of 80 of the top recruiters in the world. Because of his level of success, Michael is a sought after speaker in both industries.

Michael is the Director of Business Planning and Communication for Pfizer Medical Information in the Americas where he oversees regional projects and budgets collaborating with regional leads to define Medical Information’s global strategy as well as provides Medical Review for non-branded pieces. In 2011, he served as a key member of the team that deployed Pfizer’s first global Medical Information platform enabling the department to more easily share information, resources, and work-load globally. Currently, Michael is the business lead for Pfizer MI’s component authoring initiative which aims to minimize duplication while creating content by enabling global re-use.

Sanjay has worked in pharmaceutical marketing services for several years in a number of roles, including Director roles in leading healthcare agencies. He has a degree in biochemistry from the University of London, a degree in Medicine from Guy’s & St Thomas’ Hospital, and an MBA from the Harvard Business School. His first post-graduate thesis on pharma brand-management was developed through a collaboration with several pharmaceutical companies. His second post-graduate thesis was a study on why most healthcare communication agencies are doomed to eventual failure – for which he received a First Class commendation. Sanjay is a Fellow of the Royal Society of Medicine.

Iris Tam, PharmD, FAMCP, is Senior Vice President & Head of Medical Affairs and HEOR at COEUS Consulting with over 30 years of experience in health care, including hospital pharmacy, managed care pharmacy, and the biopharmaceutical industry. In previous industry roles, she led Medical Affairs strategies and tactics that support market access, product value, and patient access, including accountabilities for medical communications, HEOR, AMCP dossiers, compendia submissions, guideline bodies engagement, and payer communications. From 2008 to 2021, Iris served on the AMCP Format Executive Committee which oversees the AMCP Format for Formulary Submissions for dossier development, including serving as the Chair for the last 3 years.

Elizabeth Turcotte is a design thinker and marketer with sixteen years of experience in the pharmaceutical industry. In her current role as the Director of the Patient Hub at Bristol-Myers Squibb, Elizabeth is responsible for patient experience across the enterprise. She has developed design-based organizational capabilities that allow the company to innovate its patient offerings with a human-centered lens. Her team’s flagship capability is the Universal Patient Language (UPL) — a set of resources that support communicating complex topics to patients. The UPL is derived from hundreds of hours co-creating and prototyping with patients, and has been made available as an open-source capability on UPL.org.

Brandi Gregg is a pharmacist at UCB, Inc. in their patient-inspired solution center, UCBCares®. She received her Pharm.D. in 2010 from Mercer University College of Pharmacy. Her previous professional experience includes pharmacy management in a corporate retail setting and pharmacist and diabetes care coordinator at an independent compounding and retail pharmacy. Brandi is passionate about patient care and is excited to be part of the industry’s growing focus on providing patient value.

Jung began her career at AstraZeneca in 2000 and has over 17 years of Medical Affairs experience, in various roles and in multiple therapeutic areas. She started as an MSL in NYC & Philadelphia prior to beginning her HQ-based roles. Jung received a BS and PharmD from Philadelphia College of Pharmacy & Science. She completed a managed markets pharmacy residency at Advance Paradigm/University of Maryland. Prior to AZ, she was a clinical pharmacist for HIP of New York.

Christine Sunwoo currently works within Global Medical Information at Celgene, where she manages multi-channel medical communications and brings innovative solutions to internal and external audiences. Previously, Christine supported pharmaceutical clients with strategic planning and promotional activities at BGB Group, and developed her passion for medical communications while working in and leading the Medical Information group at PDR Network. Christine received her PharmD degree from Rutgers University and her MPH degree in Health Policy and Management from Columbia University in 2008 and 2015, respectively. She’s excited to be a part of healthcare at a time of explosive growth in medical technology and positively impact patients’ lives.